VEGFA and age-related macular degeneration: In an AMD model, JNK1 ablation alleviates the progression of disease manifested by decreased inflammation, reduced choroidal neovascularization, lower levels of choroidal VEGF, and a substantial reduction in choroidal apoptosis [329].